Suthee Rapisuwon, MD

Suthee Rapisuwon, MD, discusses clinical trial barriers for patients with mucosal melanoma in the United States.

Suthee Rapisuwon, MD, discusses the potential utility of toripalimab in melanoma subtypes.

Suthee Rapisuwon, MD, discusses the utility of frontline immunotherapy vs targeted therapy in acral and mucosal melanoma.

Suthee Rapisuwon, MD, discusses the biologic differences between mucosal and cutaneous melanoma.

Suthee Rapisuwon, MD, discusses the frontline treatment of acral and mucosal melanoma.